AstraZeneca Other Operating Income or Expenses 2010-2024 | AZN
AstraZeneca other operating income or expenses for the twelve months ending December 31, 2024 were $252M, a 81.19% decline year-over-year.
- AstraZeneca annual other operating income or expenses for 2024 were $0.252B, a 81.19% decline from 2023.
- AstraZeneca annual other operating income or expenses for 2023 were $1.34B, a 160.7% increase from 2022.
- AstraZeneca annual other operating income or expenses for 2022 were $0.514B, a 65.55% decline from 2021.